Delayed Thrombosis or Stenosis Following Enterprise-Assisted Stent-Coiling: Is It Safe? Midterm Results of the Interstate Collaboration of Enterprise Stent Coiling
- 1 October 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 69 (4), 908-914
- https://doi.org/10.1227/neu.0b013e318228490c
Abstract
Stent-assisted coiling of intracranial aneurysms with self-expanding stents has widened the applicability of neuroendovascular therapies to those aneurysms previously considered “uncoilable” because of poor morphology. The Enterprise Vascular Reconstruction Device and Delivery System (Cordis) has demonstrated promising initial short-term results. However, the rates of delayed in-stent stenosis or thrombosis are not known. To report midterm results of the Enterprise stent system. A 10-center registry was created to provide a large volume of data on the safety and efficacy of the Enterprise stent system. Pooled data were compiled for consecutive patients undergoing Enterprise stent-assisted coiling at each institution. Available follow-up data were evaluated for the incidence of in-stent stenosis, thrombosis, and aneurysm occlusion. In total, 213 patients (176 females) with 219 aneurysms were treated with the Enterprise stent. One hundred ten patients had undergone delayed angiography (≥30 days from stent placement, mean follow-up 174.6 days). Forty percent of patients demonstrated total occlusion with 88% having ≥90% aneurysm occlusion. Six percent of patients had delayed (>30 days) angiographic findings, of which 3% demonstrated significant (≥50%) in-stent stenosis or occlusion. Seven delayed thrombotic events occurred (3%), along with 2 additional immediate periprocedural events. All 7 delayed events were concomitant to cessation of double-antiplatelet therapy. Midterm occlusion rates are excellent, and stenosis and thrombosis rates are comparable to other available neurovascular stents. Interruption of antiplatelet therapy appears to be a factor in those developing delayed stenosis or thrombosis.Keywords
This publication has 24 references indexed in Scilit:
- Neuroform stent assisted aneurysm treatment: evolving treatment strategies, complications and results of long term follow-upJournal of NeuroInterventional Surgery, 2009
- ANGIOGRAPHIC PATTERNS OF WINGSPAN IN-STENT RESTENOSISNeurosurgery, 2008
- Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Duration, Resistance, Alternatives, and Management of Surgical PatientsThe American Journal of Cardiology, 2007
- THE EFFECT OF VASCULAR RECONSTRUCTION DEVICE-ASSISTED COILING ON PACKING DENSITY, EFFECTIVE NECK COVERAGE, AND ANGIOGRAPHIC OUTCOMENeurosurgery, 2007
- WINGSPAN IN-STENT RESTENOSIS AND THROMBOSISNeurosurgery, 2007
- NEUROFORM STENT-ASSISTED COIL EMBOLIZATION OF WIDE-NECK INTRACRANIAL ANEURYSMSNeurosurgery, 2007
- Neuroform In-Stent Stenosis: Incidence, Natural History and Treatment StrategiesNeurosurgery, 2006
- Buenos Aires experience with the Neuroform self-expanding stent for the treatment of intracranial aneurysmsJournal of Neurosurgery, 2005
- Long-Term Angiographic Recurrences After Selective Endovascular Treatment of Aneurysms With Detachable CoilsStroke, 2003
- Endovascular Treatment of Intracranial Aneurysms With Guglielmi Detachable CoilsStroke, 2002